IRVING, Texas, May 20, 2021 (GLOBE NEWSWIRE) -- For the second year in a row, HMS, a Gainwell Technologies Company, announced it has donated $20,000 to Girlstart, an organization that designs...
IRVING, Texas, March 25, 2021 (GLOBE NEWSWIRE) -- HMS (NASDAQ: HMSY), a leading provider of payment accuracy and population health management solutions, has launched a Coordination of Benefits...
Neurocrine Biosciences Set to Join S&P MidCap 400; O-I Glass to Join S&P SmallCap 600 PR Newswire NEW YORK, March 24, 2021 NEW YORK, March 24, 2021 /PRNewswire/ -- Neurocrine Biosciences...
FY'20 Total Revenue of $673.3 Million, +7.5% vs. FY'19FY'20 Net Income of $70.1 Million, -19.6% vs. FY'19FY'20 GAAP EPS of $0.78 per Diluted Share vs. $0.98 per Diluted Share in FY'19FY'20...
IRVING, Texas, Feb. 05, 2021 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (NASDAQ: HMSY), a leading provider of payment accuracy and population health management solutions, today announced that the...
IRVING, Texas, Feb. 03, 2021 (GLOBE NEWSWIRE) -- HMS (NASDAQ: HMSY), the leading provider of payment accuracy and population health management solutions, has expanded its partnership with the...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HMS Holdings Corp. PR Newswire NEW YORK, Dec. 21, 2020 NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Rowley Law PLLC is investigating...
Transaction Expands Gainwell’s Capabilities as an Analytics-Driven Healthcare Technology Provider Cotiviti to Subsequently Acquire Certain Business Lines, Expanding Health Plan...
IRVING, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (Nasdaq: HMSY) today announced it plans to participate in the Credit Suisse Virtual Healthcare Conference on Wednesday...
3Q'20 Total Revenue of $165.2 Million, (+12.5%) vs. 3Q'19 3Q'20 Net income of $18.0 Million vs. $21.1 Million in 3Q'193Q'20 GAAP EPS (Earnings Per Diluted Share) of $0.20 vs. $0.24 in 3Q'193Q'20...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約